Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Already have an ACS ID? Log in here
Already an ACS Member? Log in here
$0 Community Associate
ACS’s Basic Package keeps you connected with C&EN and ACS.
$80 Regular Members
ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.
$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students
ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.
Your account has been created successfully, and a confirmation email is on the way.
Your username is now your ACS ID.
Most Popular in Careers
- 9 ways to motivate others
- These women scientists should have won the Nobel
- Trailblazers 2021: We have been here all along
- What US chemists made in 2022, according to the ACS salary survey
- Out and proud
The Belgian specialty chemical firm Solvay will relocate its R&D activities in Paris and Aubervilliers, France, to Lyon, France, and to a lesser extent to its headquarters in Brussels as part of a big research restructuring. The move reduces the firm’s major R&D centers around the world from 21 to 19.
Under the initiative, Solvay will upgrade its Lyon R&D center, the firm’s largest, into a center for advanced chemistry. The company will also expand its R&D activities relating to materials science in Brussels. The expansion coincides with a refurbishment of the firm’s Brussels headquarters. Solvay expects about 500 employees to transfer to Brussels and Lyon from Paris and Aubervilliers over the next four years.
The initiative will lead to about 600 job cuts—equivalent to 2.5% of Solvay’s total workforce. The jobs being eliminated include 160 in France, 90 in Portugal, and 80 in Brazil. The firm has begun consultation procedures with employee representatives. Solvay says the jobs are “mainly in functional activities” but did not respond to C&EN inquiries about how many scientists are affected.
Solvay has shifted markedly away from commodity chemicals during the past six years by divesting several major businesses, including polyvinyl chloride to Ineos, nylon to BASF, and cellulose acetate to the private equity firm Blackstone.
The new R&D structure will better suit the company’s focus on specialty chemicals and tailored solutions, Solvay says. It will “provide differentiated experiences for customers and maximize value for the group,” adds CEO Jean-Pierre Clamadieu.
This article has been sent to the following recipient:
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter
Already have an ACS ID? Log in
Sign up for C&EN’s must-read weekly newsletter
Copyright © 2023 American Chemical Society. All Rights Reserved.